Comparison  	Comparison  	 NN	O
of  	of  	 IN	O
two  	two  	 CD	O
botulinum  	botulinum  	 JJ	B-NP
toxin  	toxin  	 NN	I-NP
type  	type  	 NN	I-NP
A  	A  	 DT	O
preparations  	preparations  	 NN	B-NP
for  	for  	 IN	I-NP
treating  	treating  	 VBG	I-NP
crow 	crow 	 NN	I-NP
's  	's  	 POS	O
feet 	feet 	 NNS	O
:  	:  	 :	O
a  	a  	 DT	O
split-face 	split-face 	 JJ	B-NP
,  	,  	 ,	O
double-blind 	double-blind 	 NNP	B-NP
,  	,  	 ,	O
proof-of-concept  	proof-of-concept  	 JJ	B-NP
study  	study  	 NN	I-NP
This  	This  	 DT	O
is  	is  	 VBZ	O
the  	the  	 DT	O
first  	first  	 JJ	O
double-blind 	double-blind 	 NN	B-NP
,  	,  	 ,	O
randomized 	randomized 	 NN	O
,  	,  	 ,	O
proof-of-concept  	proof-of-concept  	 JJ	B-NP
study  	study  	 NN	I-NP
to  	to  	 TO	O
compare  	compare  	 VB	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
effectiveness  	effectiveness  	 NN	I-NP
of  	of  	 IN	I-NP
botulinum  	botulinum  	 JJ	I-NP
toxin  	toxin  	 NN	I-NP
type  	type  	 NN	I-NP
A  	A  	 DT	O
( 	( 	 -LRB-	O
BoNTA 	BoNTA 	 NNP	B-NP
)  	)  	 -RRB-	O
free  	free  	 JJ	O
of  	of  	 IN	O
complexing  	complexing  	 JJ	B-NP
proteins  	proteins  	 NNS	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
BoNTA  	BoNTA  	 JJ	B-NP
complex  	complex  	 NN	I-NP
( 	( 	 -LRB-	O
BTXCo 	BTXCo 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
crow 	crow 	 NN	O
's  	's  	 POS	O
feet 	feet 	 NNS	O
.  	.  	 .	O
Twelve  	Twelve  	 NNP	O
U  	U  	 NNP	O
of  	of  	 IN	O
each  	each  	 DT	O
product  	product  	 NN	O
were  	were  	 VBD	O
compared  	compared  	 VBN	O
in  	in  	 IN	O
an  	an  	 DT	O
intra-individual  	intra-individual  	 JJ	B-NP
study  	study  	 NN	I-NP
in  	in  	 IN	O
21  	21  	 CD	O
participants  	participants  	 NNS	B-NP
with  	with  	 IN	O
a  	a  	 DT	O
facial  	facial  	 JJ	B-NP
wrinkle  	wrinkle  	 NN	I-NP
scale  	scale  	 NN	I-NP
( 	( 	 -LRB-	O
FWS 	FWS 	 NNP	B-NP
)  	)  	 -RRB-	O
score  	score  	 NN	O
of  	of  	 IN	O
2  	2  	 CD	O
to  	to  	 TO	O
3 	3 	 CD	O
.  	.  	 .	O
Evaluations  	Evaluations  	 NNS	O
were  	were  	 VBD	O
done  	done  	 VBN	O
for  	for  	 IN	O
up  	up  	 RB	O
to  	to  	 TO	O
4  	4  	 CD	O
months 	months 	 NNS	O
.  	.  	 .	O
Subjects  	Subjects  	 NNS	B-NP
with  	with  	 IN	O
an  	an  	 DT	O
improvement  	improvement  	 NN	O
of  	of  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
1  	1  	 CD	O
point  	point  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
FWS  	FWS  	 NNP	B-NP
were  	were  	 VBD	O
considered  	considered  	 VBN	B-NP
responders 	responders 	 NN	I-NP
.  	.  	 .	O
One  	One  	 CD	O
month  	month  	 NN	O
after  	after  	 IN	O
treatment 	treatment 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
responders  	responders  	 NN	B-NP
was  	was  	 VBD	O
slightly  	slightly  	 RB	O
higher  	higher  	 JJR	O
for  	for  	 IN	O
the  	the  	 DT	O
BoNTA  	BoNTA  	 JJ	B-NP
side  	side  	 NN	I-NP
( 	( 	 -LRB-	O
95 	95 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
than  	than  	 IN	O
the  	the  	 DT	O
BTXCo  	BTXCo  	 JJ	B-NP
side  	side  	 NN	I-NP
( 	( 	 -LRB-	O
90 	90 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
After  	After  	 IN	O
4  	4  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
both  	both  	 DT	O
sides  	sides  	 NNS	O
still  	still  	 RB	O
showed  	showed  	 VBD	O
good  	good  	 JJ	O
efficacy 	efficacy 	 NN	O
,  	,  	 ,	O
with  	with  	 IN	O
an  	an  	 DT	O
84 	84 	 CD	O
%  	%  	 NN	O
response  	response  	 NN	B-NP
rate  	rate  	 NN	I-NP
and  	and  	 CC	O
greater  	greater  	 JJR	O
than  	than  	 IN	O
30 	30 	 CD	O
%  	%  	 NN	O
FWS  	FWS  	 NNP	B-NP
reduction  	reduction  	 NN	I-NP
( 	( 	 -LRB-	O
no  	no  	 DT	O
statistically  	statistically  	 JJ	O
significant  	significant  	 JJ	O
difference  	difference  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
products 	products 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
After  	After  	 IN	O
1  	1  	 CD	O
month 	month 	 NN	O
,  	,  	 ,	O
FWS  	FWS  	 NNP	B-NP
score  	score  	 NN	I-NP
at  	at  	 IN	O
rest  	rest  	 NN	O
was  	was  	 VBD	O
approximately  	approximately  	 RB	O
66 	66 	 CD	O
%  	%  	 NN	O
lower  	lower  	 JJR	O
for  	for  	 IN	O
BoNTA 	BoNTA 	 NNP	B-NP
,  	,  	 ,	O
versus  	versus  	 CC	O
63 	63 	 CD	O
%  	%  	 NN	O
lower  	lower  	 JJR	O
for  	for  	 IN	O
BTXCo 	BTXCo 	 JJ	O
.  	.  	 .	O
After  	After  	 IN	O
4  	4  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
FWS  	FWS  	 NNP	B-NP
reduction  	reduction  	 NN	I-NP
was  	was  	 VBD	O
approximately  	approximately  	 RB	O
50 	50 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
Both  	Both  	 DT	O
botulinum  	botulinum  	 JJ	B-NP
toxin  	toxin  	 NN	I-NP
A  	A  	 DT	O
products  	products  	 NNS	O
displayed  	displayed  	 VBD	O
high  	high  	 JJ	O
efficacy  	efficacy  	 NN	O
and  	and  	 CC	O
good  	good  	 JJ	O
tolerability  	tolerability  	 NN	B-NP
at  	at  	 IN	O
a  	a  	 DT	O
dose  	dose  	 NN	O
ratio  	ratio  	 NN	O
of  	of  	 IN	O
1 	1 	 CD	O
: 	: 	 :	O
1 	1 	 CD	O
,  	,  	 ,	O
with  	with  	 IN	O
no  	no  	 DT	O
statistically  	statistically  	 JJ	O
significant  	significant  	 JJ	O
differences  	differences  	 NNS	O
between  	between  	 IN	O
them 	them 	 PRP	O
.  	.  	 .	O
The  	The  	 DT	O
high  	high  	 JJ	O
response  	response  	 NN	B-NP
rates  	rates  	 NNS	I-NP
observed  	observed  	 VBD	O
after  	after  	 IN	O
4  	4  	 CD	O
months  	months  	 NNS	O
suggest  	suggest  	 VBP	O
a  	a  	 DT	O
good  	good  	 JJ	O
effectiveness  	effectiveness  	 NN	O
beyond  	beyond  	 IN	O
this  	this  	 DT	O
observation  	observation  	 JJ	B-NP
period 	period 	 NN	I-NP
.  	.  	 .	O
